• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • FDA Approvals
  • New Paper Alert
  • Community
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Dec / 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Nov    
OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
  • Voices
  • FDA Approvals
  • New Paper Alert
  • Community
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Events

Advanced Urologic Cancer Consensus Conference (AUC3) 2025 - ACS Journals

Urologic Cancer

Gevorg Tamamyan: We Can Do More…

Gevorg Tamamyan

Clifford Hudis Encourages ASCO Members to Participate in the 2025 Survey as It Nears Close

Clifford Hudis

Senator Ron Johnson Thanks Secretary Kennedy for Advocacy in Early Sscreening for Rare Diseases

Ron Johnson

Arnaud Lallouette: Energy, Ambition, and Teamwork Across the Servier Performance Summit 2025 Tour

Arnaud Lallouette

Meet the 2025 BCRF-AACR Career Development Award Recipients - AACR

Events

Richard R. Barakat: A Powerful Northwell Cancer Institute–START Collaboration Bringing Early-Phase Trials to Patients

Richard R. Barakat

OncoCalendar

12 events found.

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
  • Summary
Today
  • December 2025

  • Tue 16
    AI in Precision Oncology
    Dec 16 • 8:00 PM - Dec 17 • 12:00 AM

    The State of AI in Precision Oncology 2025

    The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of […]

  • Wed 17
    EORTC
    Dec 17

    EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC

    Virtual Event

    The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature experts from medical oncology, radiation oncology, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused […]

  • Wed 17
    Bispecifics and T cell Engagers
    Dec 17 • 1:00 PM - 2:15 PM

    SITC Webinar on Bispecifics and T Cell Engagers: Practical Strategies for Recognizing and Managing Toxicities

    Virtual Event

    The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to […]

  • Wed 17
    CAR T, BMT Across the World, Going Full TILt
    Dec 17 • 2:00 PM - 3:00 PM

    Going Full TILt: Challenges, Successes, and Coordination with Administering TIL Therapy

    Virtual Event

    "Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task […]

  • January 2026

  • Thu 8
    ASCO GI
    Jan 8, 2026 • 8:00 AM - Jan 10, 2026 • 5:00 PM

    ASCO Gastrointestinal Cancers Symposium 2026

    Moscone West 800 Howard Street, San Francisco, United States

    The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]

  • Fri 9
    ASH in North America
    Jan 9, 2026 - Jan 10, 2026

    2026 Highlights of ASH in North America

    The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how […]

  • Thu 15
    MASCC
    Jan 15, 2026 • 8:00 PM

    MASCC Webinar: ADCs and Mucositis: From Mechanism to Care

    Virtual Event

    The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis. Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. […]

  • Fri 16
    Preceptorship on Breast Cancer
    Jan 16, 2026 - Jan 17, 2026

    ESMO Preceptorship on Breast Cancer 2026: Milan

    Milan, Italy

    The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]

  • Fri 16
    Cancer Immunotherapy Winter School
    Jan 16, 2026 - Jan 18, 2026

    Cancer Immunotherapy Winter School 2026

    The Westin Copley Place, Boston 10 Huntington Avenue, Boston, MA, United States

    The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]

  • Fri 16
    22nd Oncology Updates
    Jan 16, 2026 • 7:00 AM - Jan 19, 2026 • 12:00 PM

    22nd Oncology Updates: Advanced and Controversies Conference

    Steamboat Grand 2300 Mt Werner Cir, Steamboat Springs, CO, United States

    The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]

  • Fri 16
    2nd Annual Cleveland Clinic Cancer Conference
    Jan 16, 2026 • 8:00 AM - Jan 18, 2026 • 5:00 PM

    The 2nd Annual Cleveland Clinic Cancer Conference

    Margaritaville Hollywood Beach Resort 1111 N Ocean Dr, Hollywood, Los Angeles, United States

    The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]

  • Tue 20
    Oncogenic Signalling
    Jan 20, 2026 - Jan 21, 2026

    Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy

    The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: [email protected]

About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat

Oncology

OncoDaily

cancer

fight against cancer

Global fight against cancer

Breast Cancer

cancer care

ASCO

Lung cancer

Cancer research

ESMO

MD Anderson Cancer Center

Headlines

immunotherapy

NSCLC

cancer awareness

cancer treatment

Research

ASCO24

colorectal cancer

Childhood Cancer

prostate cancer

clinical trials

AACR

FDA

UICC

Dana-Farber Cancer Institute

American Cancer Society

European Cancer Organisation

SIOP

NCI

chemotherapy

National Cancer Institute

Vivek Subbiah

Myeloma

American Society of Clinical Oncology

Robert Orlowski

healthcare

Myeloma Paper of the Day

Paolo Tarantino

AI

ASCO25

IASLC

radiation oncology

Pancreatic Cancer

WHO

multiple myeloma

Memorial Sloan Kettering Cancer Center

cervical cancer

Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}